Volume 31, Number 5—May 2025
CME ACTIVITY - Synopsis
Features of Invasive Aspergillosis Caused by Aspergillus flavus, France, 2012–2018
Table 4
Main characteristics of patients with disseminated infections in a study of features of invasive aspergillosis caused by Aspergillus flavus, France, 2012–2018*
Characteristics |
Value |
Median age, y (IQR) |
36 (14.5–58) |
Sex | |
M | 3 (42.8) |
F |
4 (57.1) |
Main risk factor | |
Hematologic malignancy | 4 (57.1) |
Solid organ cancer | 1 (14.3) |
Solid organ transplant | 1 (14.3) |
Others, severe burns |
1 (14.3) |
Fever as primary clinical sign |
5 (71.4) |
Site of infection | |
Pulmonary | 6 (85.7) |
Ear, nose, throat | 2 (28.6) |
Central nervous system | 2 (28.6) |
Skin and soft tissues | 3 (42.8) |
Fungemia |
2 (28.6) |
Median time to diagnosis, d (IQR) |
5 (4.5–28) |
Positive serum galactomannan antigen, n = 5 |
5 (100) |
Proven cases |
5 (71.4) |
Fungal co-infection |
3 (42.8) |
Voriconazole first-line antifungal therapy |
6 (85.7) |
3-month case-fatality | 4 (57.1) |
*IQR, interquartile range.
1These authors contributed equally contributed to this article.
Page created: March 19, 2025
Page updated: April 29, 2025
Page reviewed: April 29, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.